Ausupreme International Holdings Limited

Ausupreme International Holdings Limited

2031.HK
Ausupreme International Holdings LimitedHK flagHong Kong Stock Exchange
0.37
HKD
+0.01
- -
281.94MMarket Cap
Ausupreme International Holdings Limited
2031.HK
(Hong Kong Stock Exchange)

Recent

price

0.37

P/E

ratio

- -

div

yld

- -

ROIC.AI

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
0.26
0.3
0.22
0.31
0.32
0.39
0.28
0.14
0.17
0.19
0.35
0.35
Revenue per Share
0.05
0.03
0.01
- -
0.02
0.04
0.02
0.01
- -
- -
0.04
0.04
Basic EPS, GAAP
0.03
0.02
0.01
0.01
-0.03
0.05
0.04
0.01
0.02
- -
0.06
0.05
Free Cash Flow per Basic Share
0.03
0.01
0.02
0.01
- -
0.01
0.03
0.01
0.01
0.01
0.01
0.02
Dividend per Share
0.05
0.08
0.06
0.1
0.1
0.13
0.01
0.11
0.1
0.09
0.12
0.14
Book Value per Share
0.05
0.08
0.07
0.23
0.22
0.25
0.24
0.23
0.22
0.2
0.23
0.25
Tangible Book Value per Share
750
750
938
666
750
750
751
762
762
762
762
762
Basic Weighted Avg Shares
195
226
211
205
242
289
211
103
129
146
269
270
Sales/Revenue/Turnover
20.93
14.27
7.6
2.84
5.77
12.49
6.33
-2.77
-2.93
0.52
14.65
12.61
Operating Margin (%)
1
2
1
1
2
3
16
16
15
15
15
16
Depreciation Expense
35
23
12
3
13
31
12
4
-1
- -
31
28
Net Income, GAAP
16.26
20.4
26.2
42.32
15.81
15.98
16.53
- -
- -
57.16
18.24
15.26
Effective Tax Rate (%)
17.69
10.26
5.83
1.5
5.17
10.79
5.72
3.74
-0.65
0.34
11.4
10.35
Profit Margin (%)
22
45
54
142
128
152
128
117
105
70
98
111
Working Capital
- -
- -
- -
- -
- -
- -
9
3
5
7
8
7
LT Debt
36
59
62
152
165
188
182
176
167
156
178
191
Total Equity
- -
40.54
15.56
2.96
7.45
17.07
5.62
- -
- -
0.18
16.96
13.84
Return on Invested Capital (%)
- -
39.76
17.13
4.75
17.88
35.38
19.63
- -
- -
0.82
31.33
24.18
Return on Capital (%)
- -
49.07
20.62
4.96
17.88
35.38
22.37
8.29
-1.04
0.68
37.82
28.2
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
17.68%
1.34%
7.29%
Free Cash Flow
426.02%
1,011.61%
-12.35%
Net Income, GAAP
598.62%
1,142.77%
-9.01%
Sales/Revenue/Turnover
7.27%
14.35%
0.2%
Total Cash Common Dividend
- -
6.86%
99.99%

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
269
2025
- -
- -
- -
- -
270
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.04
2025
- -
- -
- -
- -
0.04
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.01
2025
- -
- -
- -
- -
0.02
2026
- -
- -
- -
- -
- -
Business
Ausupreme International Holdings Limited operates as a health and personal care products company, focusing on the retail and wholesale distribution of health supplements, skincare, and related beauty and nutrition products through its brands and private-label offerings in Hong Kong, Mainland China, Macau, and Singapore, with additional consumer health and wellness categories featured in its portfolio. The company maintains a business model centered on brand management and development, sales and marketing, consumer preferences analysis, sales network development, and product delivery, leveraging a one-stop service approach to integrate after-production activities for its products. Headquartered in Hong Kong, the company is listed on the Hong Kong Stock Exchange under the ticker 2031.HK and traces its origins to a founding year that aligns with its established market presence in the health and personal care sector. Its core product families include beauty and nutrition items, brain and eye development products, immunity-enhancing formulations, skeletal and men's health supplements, and botanical detox offerings, distributed under multiple brand names such as Golden Hive, Organic Nature, and Top Life. The company’s geographic footprint encompasses key markets in Greater China and Southeast Asia, with a distribution emphasis across Hong Kong, Mainland China, Macau, and Singapore, supported by partnerships and channel expansions aimed at strengthening retail and e-commerce presence. Recent strategic moves include partnerships and alliances within the health and wellness space, expanded product launches within its health and personal care lines, and ongoing efforts to scale distribution networks and brand portfolio, reflecting an emphasis on growth in consumer health categories and international market penetration. The business operates within the health and wellness industry, with subsidiaries and potential parent company relationships structured to support brand development, product diversification, and regional expansion, and remains engaged in ongoing marketing campaigns and channel optimization to drive revenue growth and profitability. This description reflects the company’s public-facing profile as presented in market disclosures and industry references, noting its focus on health supplements, personal care products, and related wellness offerings under its branded and private-label strategies.